Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy - Top-Institutions - MDSpire

Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy

  • By

  • Florien J. G. van Amstel

  • Rik G. M. van Mierlo

  • Patty J. Nelemans

  • Sanne M. E. Engelen

  • Janneke Houwers

  • Loes F. S. Kooreman

  • Vivianne C. G. Tjan-Heijnen

  • Sabine Siesling

  • Marjolein L. Smidt

  • Thiemo J. A. van Nijnatten

  • December 23, 2025

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Surgical Oncology

  • #2

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Medical Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Surgical Oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Pathology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Oncology
    • Radiology
    • Medical Oncology

Original Source(s)

Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy

  • by Florien J. G. van Amstel, Rik G. M. van Mierlo, Patty J. Nelemans, Sanne M. E. Engelen, Janneke Houwers, Loes F. S. Kooreman, Vivianne C. G. Tjan-Heijnen, Sabine Siesling, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

  • December 23, 2025

Related Content

Evaluation of SPIO-Enhanced MRI in Distinguishing Metastatic Lymph Nodes from Reactive Hyperplasia in Breast Cancer: Diagnostic Efficacy and Correlation with VEGF-C Levels

How to practice breast self-awareness

Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial